Myelodysplastic syndromes (MDS)

EBM Guidelines
Jan 25, 2024 • Latest change Aug 22, 2025
Timo Siitonen

Table of contents

Extract

  • Myelodysplastic syndromes (MDS) are malignant blood diseases characterized by decreased haematological values and a tendency to develop into acute leukaemia.
  • MDS should be suspected particularly in an elderly patient with unexplained macrocytic anaemia, which may be associated with leucopenia or thrombocytopenia.
  • Cytopenias in the blood count result from inefficient bone marrow function caused by dysplasia i.e. a disorder of differentiation and maturation of myeloid cell lines.

Read full article of Myelodysplastic syndromes (MDS)

Search terms

Bone Marrow Examination, D46*, Erythrocyte Transfusion, Haematology, Hemoglobins, Internal medicine, Myelodysplastic Syndromes, allogeneic stem-cell transplantation, ringed sideroblast